Sanofi share price logo

Sanofi

NASDAQ: SNY

$44.24

-0.09

(-0.20%)

as on

Sanofi Stock Performance

as on September 5, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $44.02
    $44.36
    downward going graph

    0.50%

    Downside

    0.27%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $40.89
    $52.68
    downward going graph

    7.57%

    Downside

    19.08%

    Upside

    downward going graph

Sanofi share price movements today

Previous Close
$44.33
Open
$44.17
Volume
1.2M
Market Cap
$106.8B
Dividend Yield
543.95%
Day's Low - High
$44.02 - $44.36
52 Week Low - High
$40.89 - $52.68

Sanofi Historical Returns

1 Month Return
+ 3.87 %
3 Month Return
-0.11 %
1 Year Return
-2.21 %
3 Year Return
-16.56 %
5 Year Return
-14.96 %

Sanofi Stock Fundamentals & Key Indicators

Check Sanofi market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$106.8B

EPS (TTM)

4.9856

Dividend Yield

543.95%

Quarterly Earnings Growth YOY

-0.91%

PE Ratio (TTM)

23.65

Industry PE ratio

10.25

PEG Ratio

29.6012

EBITDA

13.5B

Revenue (TTM)

48.9B

Profit Margin

8.09%

Return On Equity TTM

5.71%

Sanofi Stock Valuation

Track how Sanofi P/E has moved over time to understand its valuation trends.

Sanofi in the last 5 years

  • Overview

  • Trends

Lowest (9.10x)

June 30, 2026

Industry (10.25x)

September 4, 2026

Today (23.65x)

September 4, 2026

Highest (13.38x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 23.65x

Sanofi vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sanofi with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$106.8B-14.96%23.658.09%543.9499999999999%
BUY$1.1T346.81%38.8484.01%0.58%
BUY$459.4B133.12%70.6871.48%2.7199999999999998%
BUY$653.5B59.07%32.1970.45%1.9%
BUY$369.7B97.18%120.354.77%221.58%

Stock Returns calculator for Sanofi Stock including INR - Dollar returns

The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sanofi investment value today

Current value as on today

₹1,04,816

Returns

₹4,816

(+4.82%)

Returns from Sanofi Stock

-₹2,405 (-2.4%)

Dollar Impact

₹7,221 (+7.22%)

Analyst Recommendation on Sanofi Stock

Based on 4 analysts

BUY

25.00%

Buy

75.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Sanofi. Average target price of $53.72

Sanofi Share Price Target

Get share price movements and forecasts by analysts on Sanofi.

What analysts predicted

17.65%UPSIDE

Target Price

$53.72

Current Price

$44.24

Analyzed by

4 Analysts

Target

$53.72

Sanofi target price $53.72, a slight upside of 17.65% compared to current price of $44.24. According to 4 analysts rating.

Indian Investors' Interest in Sanofi Stock

Search interest for Sanofi Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-5% versus previous 30 day period

Sanofi Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
10,571
12,245
15,720
7,983
11,469
10,735
13,170
12,205
11,244
12,300
Gross Profit
7,344
8,576
11,184
5,607
8,345
7,743
9,758
8,575
8,106
9,283
Operating Income
1,236
1,595
3,635
573
2,233
1,474
3,623
-1,038
2,269
2,384
EBITDA
1,867
2,026
4,247
563
2,770
1,889
4,198
3,823
2,716
1,676
Interest Expense
247
304
265
302
213
201
227
100
178
287
Depreciation
562
499
479
209
399
378
461
538
535
552
Income Before Tax
1,093
1,416
3,581
451
2,200
1,467
3,508
-1,155
2,014
828
Income Tax Expense
104
299
737
4
481
230
680
-348
420
451
Net Income
1,231
1,197
3,125
522
2,024
3,940
2,802
-801
1,614
343
Net Profit Margin
11.65%
9.78%
19.88%
6.54%
17.65%
36.70%
21.28%
-6.56%
14.35%
2.79%

Sanofi Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
36,572
42,854
40,583
41,816
45,452
44,285
42,923
45,400
46,333
46,716
Gross Profit
25,292
29,114
27,576
28,505
30,663
30,431
30,349
31,624
32,517
33,667
Operating Income
6,531
5,804
4,676
3,051
14,113
8,126
10,162
6,960
7,252
9,597
EBITDA
9,900
9,637
9,179
10,662
17,883
11,538
13,510
11,390
11,033
12,479
Interest Expense
399
333
486
536
430
377
384
512
622
626
Depreciation
-
3,686
4,279
7,452
3,684
1,580
2,053
4,792
3,586
5,678
Income Before Tax
5,811
5,616
4,904
3,007
14,137
7,837
9,992
6,115
6,758
6,020
Income Tax Expense
1,325
1,722
481
121
1,807
1,558
1,909
1,017
1,204
1,043
Net Income
4,963
9,957
4,898
3,060
14,953
7,034
8,858
5,890
5,817
7,813
Net Profit Margin
13.57%
23.24%
12.07%
7.32%
32.90%
15.89%
20.64%
12.98%
12.55%
16.72%

Sanofi Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
2,209
2,815
683
1,872
3,940
2,802
-801
1,614
343
Operating Cash Flow
1,536
3,848
-
2,093
1,462
3,750
3,445
1,683
5,416
Investing Cash Flow
-3,688
-
-
-776
-
-9,043
-2,131
-2,278
-3,083
Financing Cash Flow
96
-1,872
-
-592
-3,857
-1,148
-2,570
-1,527
-3,886
Change in Cash
-2,338
-
-
550
7,368
-6,453
-1,249
-2,113
-1,415

Sanofi Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
8,434
4,306
2,754
12,294
6,223
8,371
5,062
5,496
5,574
Operating Cash Flow
7,379
5,547
7,715
7,418
10,522
10,526
10,258
9,081
12,132
Investing Cash Flow
639
-12,872
-1,212
3,588
-7,298
-2,075
-6,200
-4,407
-2,761
Financing Cash Flow
-7,902
3,934
-4,193
-6,485
-7,056
-5,821
-8,052
-5,763
-9,262
Change in Cash
42
-3,390
2,502
4,488
-3,817
2,638
-4,026
-1,269
970

Mutual Funds that own Sanofi Stock

Check out the Mutual Funds with significant holdings in Sanofi.

Funds
Holdings
Shares Held
Dodge & Cox Funds
0.961289%
23220389
AIM Sector Funds (Invesco Sector Funds)
0.166704%
4026820
T. ROWE PRICE EQUITY INCOME FUND, INC.
0.074144%
1791000
Bridge Builder Trust
0.070253%
1697011
American Mutual Fund
0.065316%
1577744

Global Institutional Holdings in Sanofi

Funds
Holdings
John A. Gunn
1.16%
Ken Fisher
0.44%
Charles Brandes
0.17%
George Davis Jr
0.08%
Bill Manning
0.05%

Sanofi News & Key Events

  • img

    Today's Timeline - 28 August

    Fri, 06:05 PM

    -

    Sanofi leads Nuvaxovid commercial activities, expanding vaccine reach in major markets for 2026-2027.

    Fri, 09:15 PM

    -

    Sanofi's Dupixent sales rose 28.6% to €9.3 billion in H1 2026, with strong uptake of new medicines.

    Fri, 10:00 PM

    -

    Sanofi updates Lunsekimig COPD study, focusing on long-term safety and efficacy for chronic obstructive pulmonary disease.

Insights on Sanofi

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Sanofi ADS has shown positive revenue growth over the last two quarters. Revenue increased from $11.24 billion to $12.3 billion, representing an average quarter-on-quarter growth of 8.6%.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Merck & Co., Inc. has given 77.5% return, outperforming this stock by 82.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly & Co. has given 41.2% return, outperforming this stock by 57.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Sanofi ADS has experienced a significant decline in net profit over the last two quarters. It dropped from $1.61 billion to $342.99 million, averaging a decrease of 78.8% per quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SNY stock has moved down by -1.3%

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
OrganisationSanofi
Headquarters46, avenue de la Grande ArmEe, Paris, France, 75017
IndustryDrug Manufacturers - General
CEOMs. Belen Garijo Lopez M.D.
E-voting on sharesClick here to vote

Key Management of Sanofi

Name

Title

Mr. François-Xavier Roger

Executive VP & CFO

Mr. Erik Wallström

Head of Therapeutic Area - Neurology Development

Mr. Thomas Triomphe

Executive Vice President of Vaccines

Mr. Pablo Sardi

TA Head of Rare & Neurologic Diseases Research

Ms. Belen Garijo Lopez M.D.

CEO & Director

Dr. Michael Quigley Ph.D.

Chief Scientific Officer & Head of Research

Mr. Thomas Kudsk Larsen

Head of Investor Relations & General Medicines

Mr. Pierre Chancel

Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing

Fabrizio Gaudi

Head of Austrian, German & Swiss Operations

Dr. Karin Knobe

TA Head of Rare Diseases & Rare Blood Disorders Development

FAQs

What is Sanofi share price today?

Sanofi share price today is $44.24 as on at the close of the market. Sanofi share today touched a day high of $44.36 and a low of $44.02.

What is the 52 week high and 52 week low for Sanofi share?

Sanofi share touched a 52 week high of $52.68 on and a 52 week low of $40.89 on . Sanofi stock price today i.e. is closed at $44.24,which is 16.02% down from its 52 week high and 8.19% up from its 52 week low.

What is Sanofi's market capitalisation today?

Sanofi market capitalisation is $0.11T as on .

How to invest in Sanofi Stock (SNY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sanofi on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sanofi Shares that will get you 0.0339 shares as per Sanofi share price of $44.24 per share as on September 5, 2026 at 8:45 am IST.

What is the minimum amount required to buy Sanofi Stock (SNY) from India?

Indian investors can start investing in Sanofi (SNY) shares with as little as ₹94.49 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.90 in Sanofi stock (as per the Rupee-Dollar exchange rate as on ). Based on Sanofi share’s latest price of $44.24 as on September 5, 2026 at 8:45 am IST, you will get 0.2260 shares of Sanofi. Learn more about fractional shares .

What are the returns that Sanofi has given to Indian investors in the last 5 years?

Sanofi stock has given -14.96% share price returns and 29.3% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?